The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Benitec Biopharma Inc(NASDAQ:BNTC) 
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based ...
Website: http://www.benitec.com
Founded: 1997
Full Time Employees: 14
Sector: Healthcare
Industry: Biotechnology
Benitec Biopharma Days Payable Outstanding ttm (DPO)
Benitec Biopharma Days Receivable Outstanding ttm (DSO)
Benitec Biopharma Days Inventory Outstanding ttm (DIO)
Benitec Biopharma Op Cashflow Per Share ttm
Benitec Biopharma Free Cashflow Per Share ttm
Benitec Biopharma Cash Per Share ttm
Benitec Biopharma P/S ratio ttm
Benitec Biopharma (GAAP) P/E ratio ttm
Benitec Biopharma P/B ratio ttm
No extra charts and metrics for this ticker.